Singapore markets open in 2 hours 26 minutes

Amarin Corporation plc (AMRN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.8833+0.0176 (+2.03%)
At close: 04:00PM EDT
0.9000 +0.02 (+1.89%)
After hours: 06:17PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.8657
Open0.8700
Bid0.8785 x 400
Ask0.8848 x 200
Day's range0.8674 - 0.8980
52-week range0.6500 - 1.4900
Volume760,481
Avg. volume1,691,285
Market cap354.517M
Beta (5Y monthly)2.01
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Amarin Announces Results of Annual General Meeting of Shareholders

    - Shareholders Approve Share Repurchase Program of up to $50 Million -DUBLIN, Ireland and BRIDGEWATER, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced shareholder approval of all proposed resolutions specified at its 2024 Annual General Meeting (AGM). Importantly, shareholders approved each of the two proposals required for the Company to proceed with its previously announced intent to pursue a share repurchase program of up to $50 million. This perm

  • GlobeNewswire

    Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024

    DUBLIN, Ireland and BRIDGEWATER, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Patrick Holt, President & CEO, and members of Amarin’s senior management team to discuss its first quarter 2024 results followed by Q&A on Wednesday, May 1st, 2024, at 8:00 a.m. ET. The conference call with management will follow the release of the Company’s first quarter 2024 financial results in the pre-market hours. To enhance

  • GlobeNewswire

    Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24

    Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanism of ActionDUBLIN, Ireland and BRIDGEWATER, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted three data presentations at ACC.24 showcasing the mechanistic activity of Eicosapentaenoic acid (EPA), including the potential effects of EPA on endothelial cell dysfunction and on oxidation of samples enriched with Lp(a). ”The data presented at ACC.24 provide new evidence surrounding